12.12.2023 • News

Syensqo is Created Following Demerger of Solvay

Solvay’s shareholders supported the separation with 99.53 % approval, giving official birth to Syensqo.

As the Extraordinary General Shareholders’ Meeting of Solvay closed last week with massive support (+99.53%) of shareholders, Syensqo will be officially demerged from Solvay.

“This is a historical moment,” commented Ilham Kadri, incoming CEO of Syensqo. “This turning point highlights the recognition and success of the in-depth transformation of Solvay in the past 5 years. I want to thank all our shareholders, board members, and teams for their trust, and for making this ambitious project come true. I also wish the new Solvay a very bright future."

Solvay's newly established pure-play company, among the world's largest, is set to uphold the innovative legacy of its founder Ernest Solvay. Branded as Syensqo, the company aims to enhance its innovation capabilities, serving customers' environmental goals, achieving carbon neutrality by 2040, and driving growth in disruptive technologies.

Solvay’s extraordinary shareholders’ meeting supported the separation with...
Solvay’s extraordinary shareholders’ meeting supported the separation with 99.53 % of positive votes, giving official birth to Syensqo. © Syensqo

Company

Syensqo

rue de la Fusée 98
B-1130 Brussels
Belgium

Company contact







Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read